pfizer glp-1 agonist Oral Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies Orforglipron, an Oral Small-Molecule GLP-1

National Taiwan University researchers highlight the benefits of GLP-1 receptor agonists (GLP-1 RAs) in reducing mortality and severe cardiovascular and renal outcomes for diabetic patients with acute kidney disease (AKD)

2026: Acceleration and Market Transformation The coming year promises rapid evolution across innovation, policy, and market access

Future research should focus on elucidating the complex mechanisms underlying their psychological effects and integrating mental health considerations into therapeutic strategies

Citing its post-market evaluation that found no increased risk of suicidal ideation or behavior, the U.S

Learn how GLP-1s can positively impact your wellness journey.

The FDA has laid out post-marketing safety testing requirements for Lilly's weight-loss pill Foundayo, including clinical trials.